Details of the Drug

General Information of Drug (ID: DMI7VQU)

Drug Name

Captisol-enabled Melphalan

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled (Propylene Glycol-Free) Melphalan. Spectrum Pharmaceuticals. October 23, 2015.